D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 81 Citations 23,964 360 World Ranking 658 National Ranking 18
Medicine D-index 81 Citations 23,315 362 World Ranking 11399 National Ranking 155

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Bacteria
  • Antibiotics

Antonio Oliver spends much of his time researching Microbiology, Pseudomonas aeruginosa, Antibiotics, Antibacterial agent and Antibiotic resistance. His Microbiology study combines topics in areas such as Beta-lactamase and Multilocus sequence typing, Genotype. His study in Pseudomonas aeruginosa is interdisciplinary in nature, drawing from both Multiple drug resistance, Drug resistance and Integron.

His work carried out in the field of Antibiotics brings together such families of science as Intensive care medicine, Cystic fibrosis, Combination therapy and Biofilm. Antonio Oliver combines subjects such as Plasmid, Nucleic acid sequence and Escherichia coli with his study of Antibacterial agent. The study incorporates disciplines such as Microbial resistance and Proa in addition to Antibiotic resistance.

His most cited work include:

  • High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection (1211 citations)
  • Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. (707 citations)
  • ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014 (355 citations)

What are the main themes of his work throughout his whole career to date?

Antonio Oliver mostly deals with Microbiology, Pseudomonas aeruginosa, Antibiotic resistance, Antibiotics and Ceftazidime. Microbiology connects with themes related to Biofilm in his study. His Pseudomonas aeruginosa research includes themes of Multiple drug resistance, Cystic fibrosis, Mutant and Virulence.

His Antibiotic resistance research is multidisciplinary, incorporating perspectives in Ciprofloxacin, Respiratory infection and Genotype. Antonio Oliver has researched Antibiotics in several fields, including Antimicrobial, Bacteria, Efflux, Combination therapy and Klebsiella pneumoniae. His Ceftazidime research incorporates elements of Tazobactam and Cephalosporin.

He most often published in these fields:

  • Microbiology (63.59%)
  • Pseudomonas aeruginosa (52.94%)
  • Antibiotic resistance (21.29%)

What were the highlights of his more recent work (between 2018-2021)?

  • Pseudomonas aeruginosa (52.94%)
  • Microbiology (63.59%)
  • Antibiotics (17.65%)

In recent papers he was focusing on the following fields of study:

His main research concerns Pseudomonas aeruginosa, Microbiology, Antibiotics, Antibiotic resistance and Ceftolozane. The study incorporates disciplines such as Multiple drug resistance, Pathogen, Phenotype, Genome and Virulence in addition to Pseudomonas aeruginosa. Antonio Oliver has included themes like Ceftazidime and Multilocus sequence typing in his Microbiology study.

The concepts of his Antibiotics study are interwoven with issues in Mutation, Efflux, Cystic fibrosis and Biofilm. His biological study spans a wide range of topics, including Lactam and Ciprofloxacin. His research investigates the connection between Ceftolozane and topics such as Tazobactam that intersect with issues in Broth microdilution, Drug resistance, Respiratory tract infections and Amikacin.

Between 2018 and 2021, his most popular works were:

  • Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. (707 citations)
  • Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections (82 citations)
  • Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia. (31 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Bacteria
  • Antibiotics

The scientist’s investigation covers issues in Pseudomonas aeruginosa, Microbiology, Antibiotics, Antibiotic resistance and Multiple drug resistance. Antonio Oliver combines subjects such as Phenotype, Antimicrobial, Clone, Combination therapy and Drug resistance with his study of Pseudomonas aeruginosa. The Microbiology study combines topics in areas such as Lactam and Multilocus sequence typing.

His work deals with themes such as Internal medicine and Cystic fibrosis, which intersect with Antibiotics. His Antibiotic resistance research integrates issues from Biofilm, Mutation, Gene, Mutant and Whole genome sequencing. His Multiple drug resistance study incorporates themes from Klebsiella pneumoniae and Acinetobacter baumannii.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection

Antonio Oliver;Rafael Cantón;Pilar Campo;Fernando Baquero.
Science (2000)

1698 Citations

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.

Marina Pollán;Beatriz Pérez-Gómez;Roberto Pastor-Barriuso;Jesús Oteo.
The Lancet (2020)

1580 Citations

ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014

N. Høiby;T. Bjarnsholt;C. Moser;G. L. Bassi.
Clinical Microbiology and Infection (2015)

604 Citations

Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli

Jesús Rodríguez-Baño;Juan C. Alcalá;Jose M. Cisneros;Fabio Grill.
JAMA Internal Medicine (2008)

542 Citations

The increasing threat of Pseudomonas aeruginosa high-risk clones.

Antonio Oliver;Xavier Mulet;Carla López-Causapé;Carlos Juan.
Drug Resistance Updates (2015)

488 Citations

OXA-24, a Novel Class D β-Lactamase with Carbapenemase Activity in an Acinetobacter baumannii Clinical Strain

Germán Bou;Antonio Oliver;Jesús Martínez-Beltrán.
Antimicrobial Agents and Chemotherapy (2000)

445 Citations

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

Belén Gutiérrez-Gutiérrez;Elena Salamanca;Marina de Cueto;Po-Ren Hsueh.
Lancet Infectious Diseases (2017)

431 Citations

Community-Onset Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: Risk Factors and Prognosis

Jesuús Rodríguez-Baño;Encarnación Picón;Paloma Gijón;José Ramón Hernández.
Clinical Infectious Diseases (2010)

429 Citations

Antimicrobial susceptibility testing in biofilm-growing bacteria

M.D. Macia;E. Rojo-Molinero;A. Oliver.
Clinical Microbiology and Infection (2014)

389 Citations

Hypermutation Is a Key Factor in Development of Multiple-Antimicrobial Resistance in Pseudomonas aeruginosa Strains Causing Chronic Lung Infections

María D. Maciá;David Blanquer;Bernat Togores;Jaume Sauleda.
Antimicrobial Agents and Chemotherapy (2005)

386 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Antonio Oliver

Rafael Cantón

Rafael Cantón

Instituto Ramón y Cajal de Investigación Sanitaria

Publications: 132

Jesús Rodríguez-Baño

Jesús Rodríguez-Baño

University of Seville

Publications: 89

Álvaro Pascual

Álvaro Pascual

University of Seville

Publications: 80

Niels Høiby

Niels Høiby

University of Copenhagen

Publications: 68

Robert A. Bonomo

Robert A. Bonomo

Case Western Reserve University

Publications: 67

Matteo Bassetti

Matteo Bassetti

University of Genoa

Publications: 60

Fernando Baquero

Fernando Baquero

Cajal Institute

Publications: 60

Patrice Nordmann

Patrice Nordmann

University of Fribourg

Publications: 58

Luis Martínez-Martínez

Luis Martínez-Martínez

University of Córdoba

Publications: 56

Germán Bou

Germán Bou

University of A Coruña

Publications: 56

Thomas Bjarnsholt

Thomas Bjarnsholt

University of Copenhagen

Publications: 53

David L. Paterson

David L. Paterson

University of Queensland

Publications: 52

David M. Livermore

David M. Livermore

University of East Anglia

Publications: 50

Angus Buckling

Angus Buckling

University of Exeter

Publications: 45

Laurent Poirel

Laurent Poirel

University of Fribourg

Publications: 44

Oana Ciofu

Oana Ciofu

University of Copenhagen

Publications: 42

Trending Scientists

Yvan Labiche

Yvan Labiche

Carleton University

Jieping Ye

Jieping Ye

Arizona State University

Jeffrey L. Callen

Jeffrey L. Callen

University of Toronto

Carlo Atzeni

Carlo Atzeni

University of Florence

Paschalis Alexandridis

Paschalis Alexandridis

University at Buffalo, State University of New York

Edward G. Janzen

Edward G. Janzen

University of Guelph

Thomas A. Lograsso

Thomas A. Lograsso

Ames Laboratory

Malcolm K. Jones

Malcolm K. Jones

University of Queensland

Peter K. Zeitler

Peter K. Zeitler

Lehigh University

David N. Petley

David N. Petley

University of Sheffield

Pietro Baldelli

Pietro Baldelli

University of Genoa

Carsten N. Boehler

Carsten N. Boehler

Ghent University

Rodney J. Douglas

Rodney J. Douglas

ETH Zurich

Rita Sloan Berndt

Rita Sloan Berndt

University of Maryland, Baltimore

Fernando Schmitt

Fernando Schmitt

University of Porto

M. E. Huber

M. E. Huber

Technical University of Munich

Something went wrong. Please try again later.